Genomic Applications Partnership Program (GAPP)
GAPP Investment Strategy and Guidelines
Expression of Interest Forms
Supplementary Proposal Forms
GAPP Funded Projects
The Genomic Applications Partnership Program (GAPP) represents a key element in Genome Canada’s strategic plan towards funding downstream research and development (R&D) projects that address real world challenges and opportunities as identified by industry, government, not-for-profits and other “Users” of genomics research.
Genome Canada is a catalyst for developing and applying genomics for the benefit of Canadians. Genome Canada builds bridges between government, academia and industry to forge a genomics-based public-private innovation enterprise focused on key life science sectors (human health, agriculture, fisheries, forestry, energy, mining, and environment). Genome Canada and the regional Genome Centres have made significant investments in large-scale genomics1 research and leading-edge technologies which has allowed Canada to become a leader in the field of genomics. We are now focusing a significant amount of effort to build and improve ways of translating discoveries into new applications by enabling the transfer of knowledge and technologies from Academia to the User community in ways that will maximize the impact of this initial investment and lead to economic and social benefits for Canada.
The GAPP aims to:
- promote the application of genomics-derived solutions to address key sector challenges or opportunities facing Users - User “pull”;
- promote commercialization of genomics technologies by enabling the transfer of genomics-derived solutions from Academia to Users as well as de-risking and incentivizing follow-on investment from public and private partners;
- increase the socio-economic impact of genomics research by accelerating its translation to application or market; and,
- create and foster a more productive interface between Academia and Users.
- Up to $30 million is available from Genome Canada for this program.
- Genome Canada will provide support for projects, ranging in size from $300,000 to $6 million in total project budget, with the Genome Canada investment not to exceed more than 1/3 of the total investment in the project by all parties. The remaining 2/3 must be secured through co-funding with at least 1/3 provided by the User(s) (see Section 9 and Appendix 2 of the GAPP Investment Strategy and Guidelines for more details on co-funding).
- Generally, the project term should be a minimum of six months to a maximum of three years. A shorter or longer term will be considered, but only if a strong rationale is provided.
For further information on the GAPP, please refer to the GAPP overview slide-deck and GAPP Investment Strategy and Guidelines
There is a three-stage gated application process for this program:
- Expression of Interest (EOI)
- Project Pitch
- Supplementary Proposal
EOIs must be submitted to Genome Canada through a Genome Centre (see Contacts) and will be accepted at any time, until all funding has been committed. There will be two rounds per year for evaluating supplementary proposals and future cut-off dates for submission of these at Genome Canada (contact your regional Genome Centre for their preliminary deadline) are as follows:
Deadlines for Submission of Supplementary Proposals
Round 3: September 22, 2014 (for December 2014 approval)
Round 4: March 27, 2015 (for June 2015 approval)
Round 5: September 25, 2015 (for December 2015 approval)
Round 6: March 26, 2016 (for June 2016 approval)
Note: All reviewers at all stages of the process will have signed confidentiality and conflict of interest forms to ensure information is kept in strict confidence.
Expression of Interest (EOI)
The EOI will be reviewed by the Genomic Applications Programs Portfolio Manager (GAP PM) to determine eligibility for the program. Applicants will normally be informed within two weeks whether their application is considered eligible and invited to present a project pitch.
To help ensure that projects are ready to proceed to the Supplementary Proposal stage, the project team, including both the Academic and User Project Leaders, will be invited to pitch their project to the GAP PM and external technical and industry experts via teleconference. Projects must present their EOI and pitch through a slide presentation. Normally, within one week following the pitch, the project teams will be informed whether they are invited to submit a Supplementary Proposal or further development is required.
The Supplementary Proposal will focus on the technical aspects and a complete budget. In addition, any questions arising from the pitch will need to be addressed. External technical and industry experts, and Genome Canada staff, as required, will be involved in the review of the Supplementary Proposal.
Core Evaluation Team
Genome Canada has established a Core Evaluation Team (CET) composed of external experts with expertise in business development, commercialization, public policy, socio-economic benefit analysis, IP, financing, venture capital, etc. The CET meets every round to review the proposals and the reports from the reviewers and to make recommendations to Genome Canada regarding funding. The CET will also be involved in the ongoing monitoring of funded projects.
 The term genomics is defined here as the comprehensive study, using high throughput technologies, of the genetic information of a cell or organism, including the function of specific genes, their interactions with each other and the activation and suppression of genes. For purposes of describing Genome Canada’s mandate it also includes related disciplines such as bioinformatics, epigenomics, metabolomics, metagenomics, nutrigenomics, pharmacogenomics, proteomics and transcriptomics.